EGFR T790M Inhibitor 80mg Generic Tablet

Osimertinib is for treating NSCLC with a therapy that zeroes in on specific targets. It works by blocking the EGFR mutations, mainly the T790M one, in the EGFR. The drug comes in two doses, 40 and 80 mg, and is in a tablet form with a coating.

For adults, the recommended dose is 80 mg, and you can take it with or without food, but daily for sure. It comes in bottles with 30 tablets, making it easy to take and stick to the treatment plan. Osimertinib controls the disease by keeping the EGFR from making cells divide and grow too much.